Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand common and serious Yupelri (revefenacin) side effects for COPD treatment. Learn when to seek medical attention, how to manage symptoms, and important precautions for safe use. This guide covers everything from mild reactions to severe complications like paradoxical bronchospasm, glaucoma, and urinary retention, ensuring you're well-informed.
Sleeping tablets can help manage insomnia and sleep disorders when used correctly. This guide explains types, benefits, risks, and safe usage tips for better sleep health.
April 11, 2026
Explore the short-term and long-term effects of Adderall on the brain, including its uses, side effects, risks of misuse, and the importance of medical supervision for safe and effective treatment.
April 1, 2026
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that makes breathing difficult. It affects millions worldwide, often leading to significant impairment in daily activities. While there is no cure for COPD, various treatments aim to manage symptoms, improve lung function, and enhance quality of life. Among these treatments is Yupelri (revefenacin), a long-acting muscarinic antagonist (LAMA) administered via nebulization.
Yupelri works by relaxing the muscles around the airways in your lungs, helping them to stay open and making breathing easier. It is prescribed for the long-term, maintenance treatment of airflow obstruction in patients with COPD. Like all medications, Yupelri can cause side effects. Understanding these potential side effects, both common and serious, is crucial for anyone using this medication. This comprehensive guide will delve into Yupelri's side effects, providing essential information to help you manage your treatment effectively and safely in consultation with your healthcare provider.
COPD is an umbrella term for a group of progressive lung diseases, including emphysema and chronic bronchitis, that cause obstructed airflow from the lungs. Symptoms often include shortness of breath, cough, mucus production, and wheezing. Long-term exposure to irritants, particularly cigarette smoke, is the primary cause. COPD is a chronic condition, meaning it requires ongoing management to control symptoms and prevent exacerbations.
Yupelri contains revefenacin, an anticholinergic medication. Anticholinergics block the action of acetylcholine, a neurotransmitter that causes muscles in the airways to constrict. By blocking this action, revefenacin helps to relax the smooth muscles in the bronchi, leading to bronchodilation (widening of the airways). This effect is sustained, providing long-lasting relief from bronchoconstriction, which is a hallmark of COPD.
Yupelri is delivered as a solution for nebulization. This method allows the medication to be inhaled directly into the lungs, where it can act locally to open the airways. Nebulized treatments are particularly beneficial for patients who may have difficulty using metered-dose inhalers or dry powder inhalers effectively, or for those who prefer the ease of nebulizer use.
Many individuals using Yupelri experience mild to moderate side effects. These are typically manageable and often improve as your body adjusts to the medication. It's important to discuss any persistent or bothersome side effects with your doctor.
A persistent cough is one of the most frequently reported side effects. While Yupelri is meant to improve breathing, some individuals may experience an increase in coughing, especially shortly after administration. This can be due to irritation of the airways or the body's reaction to the inhaled medication.
Due to the nature of inhaled medications, some patients may experience symptoms resembling a common cold. This can manifest as nasal congestion, a runny nose, or a sore throat.
Headaches are a common complaint with many medications, including Yupelri. They are usually mild and may subside with continued use.
Some individuals report experiencing back pain while taking Yupelri. The exact mechanism for this is not fully understood but is a reported adverse event.
Feeling unusually tired or fatigued is another side effect that some patients may experience.
Digestive issues, such as diarrhea, can occur in some individuals using Yupelri.
Nausea, with or without vomiting, can also be a side effect.
Involuntary muscle contractions or spasms have been reported.
While Yupelri is intended to improve breathing, in some rare cases, patients may experience worsening shortness of breath or paradoxical bronchospasm, especially immediately after administration. This is a serious side effect and should be treated as such.
While less common, some side effects of Yupelri can be serious and require immediate medical attention. It is vital to be aware of these and know when to seek help.
This is a rare but severe reaction where the medication, instead of relaxing the airways, causes them to narrow or constrict. This can be life-threatening.
Yupelri, being an anticholinergic, can affect the eyes, potentially leading to or worsening narrow-angle glaucoma. This condition causes increased pressure inside the eye, which can damage the optic nerve and lead to vision loss if not treated promptly.
Anticholinergic medications can also affect the bladder and urinary tract, potentially causing or exacerbating urinary retention, particularly in men with an enlarged prostate (benign prostatic hyperplasia, BPH).
Like any medication, Yupelri can cause severe allergic reactions, though they are rare.
Several factors can influence the likelihood and severity of side effects when using Yupelri:
It is crucial to inform your doctor about all medications you are taking, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements, to avoid potential drug interactions.
The most significant interaction concern with Yupelri is with other anticholinergic drugs. Using multiple anticholinergics can lead to an additive effect, increasing the risk of side effects such as dry mouth, blurred vision, urinary retention, and constipation. Examples include other bronchodilators (like tiotropium, ipratropium), certain antihistamines, tricyclic antidepressants, and some medications for Parkinson's disease.
Your doctor will evaluate your current medication list to ensure that there are no significant interactions or will advise on how to safely manage them.
Before starting Yupelri, and throughout your treatment, your doctor will consider certain warnings and precautions to ensure your safety and the effectiveness of the medication.
Yupelri is a maintenance treatment for COPD and is not intended for the rapid relief of acute bronchospasm (sudden attacks of shortness of breath). You should always have a fast-acting rescue inhaler available for such episodes.
The safety of Yupelri during pregnancy and breastfeeding has not been extensively studied in humans. If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential risks and benefits with your doctor.
Yupelri is approved for use in adults with COPD. Its safety and efficacy in pediatric patients have not been established. Older adults (65 years and older) may be more susceptible to the side effects of anticholinergic medications, particularly urinary retention and glaucoma, and should be monitored closely.
Knowing when to seek medical advice for side effects is crucial for safe and effective treatment with Yupelri.
Managing COPD effectively involves more than just taking medication. It requires a holistic approach that includes adherence to your treatment plan, lifestyle modifications, and regular communication with your healthcare team.
A: Yes, Yupelri is designed for long-term, maintenance treatment of COPD. Its safety and efficacy have been evaluated in clinical trials for extended periods. However, long-term use requires ongoing monitoring by your doctor for side effects and overall treatment effectiveness.
A: Weight gain is not a commonly reported side effect directly associated with Yupelri in clinical studies. If you experience unexplained weight changes, discuss them with your doctor, as it could be related to other factors or underlying health conditions.
A: Common side effects like cough or headache might appear shortly after starting the medication. Serious side effects like paradoxical bronchospasm would typically occur immediately after administration. Other serious effects like worsening glaucoma or urinary retention might develop over time, especially if you have pre-existing risk factors.
A: If you miss a dose, take it as soon as you remember, unless it's almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular schedule. Do not take two doses at once to make up for a missed dose.
A: There are no specific known interactions between Yupelri and alcohol. However, alcohol can impair judgment and worsen some COPD symptoms or general health. It's always best to consume alcohol in moderation or discuss it with your doctor, especially if you have other health conditions or are taking other medications.
A: No, Yupelri is not considered addictive. It is a bronchodilator that works locally in the lungs and does not have properties that lead to physical dependence or addiction.
Yupelri (revefenacin) is a valuable medication for the long-term management of COPD, offering significant benefits in improving breathing and quality of life. While it is generally well-tolerated, understanding its potential side effects is a critical aspect of safe and effective treatment. Most side effects are mild and manageable, but some can be serious and require immediate medical attention.
Always maintain open and honest communication with your healthcare provider. Report any new or worsening symptoms, discuss all medications you are taking, and follow their instructions diligently. By being informed and proactive, you can work collaboratively with your medical team to optimize your COPD treatment plan, minimize risks, and achieve the best possible outcomes for your respiratory health.
Remember, this article provides general information and should not replace personalized medical advice from a qualified healthcare professional. If you have any concerns about Yupelri or your COPD, always consult your doctor.
Curious if Pepto-Bismol can help your stomach after drinking? We explore the potential risks and what the research says about mixing Pepto-Bismol and alcohol, plus safer alternatives for hangover relief.
April 1, 2026